Jane Lauder | Founder, TAW Ventures

After nearly three decades helping build one of the most trusted portfolios in consumer brand history, Jane Lauder is now applying those same standards of rigor, trust, and long-term brand equity to the pet industry.

Through TAW Ventures, she's backing founders working at the intersection of science, longevity, and the human–animal bond — areas she believes are still underestimated despite the surge of capital into pet.

In this conversation, Jane shares how prestige beauty principles translate into pet health, what separates durable brands from short-term trends, and where she sees the biggest white space emerging over the next decade.

‍

You spent nearly 30 years inside The Estée Lauder Companies. How did that experience prepare you for this new chapter in your professional career?

I grew up professionally at The Estée Lauder Companies, and those years shaped how I think as a leader. I learned how to build brands that become part of people's daily routines, which is incredibly personal. So much of that is about earning trust and creating an emotional connection. In prestige beauty, consumers are discerning and informed. They expect products to work, they expect transparency, and they expect proof behind every promise.

I've found that mindset translates directly to pet health and wellness. Today's pet parents are asking the same kinds of questions I saw emerge in beauty: What's in this? Does it work? Can I trust who is behind it? After nearly three decades where quality, efficacy, and consumer trust were non-negotiable, moving into pet felt less like a career pivot and more like an opportunity to apply those same principles to a category I'm deeply passionate about.

‍

What was the original spark behind starting TAW Ventures — and when did it shift from an idea to something you knew you had to pursue?

TAW Ventures began with my dog, our namesake, Thaddeus Alistair Warsh (TAW). In the summer of 2024, Thaddeus started having sudden episodes where he couldn't stand. It was terrifying and heartbreaking to see someone I love so much in distress and not being able to fix it. We went through multiple vets and tests without a clear answer. Through my own research and process of elimination, I came to believe a common preventive medication was the likely trigger. When we stopped it, he returned to his happy, healthy self.

That experience made me look at pet care through a different lens. I realized there was a gap between the standards we expect for our own health and what existed for our pets. I found myself reading labels differently, asking more questions, and wishing there were more brands bringing real rigor, transparency, and clinical thinking into pet health.

Once I started meeting with founders who were trying to build exactly that kind of company—but didn't have the support they needed, I realized how much I wanted to pursue this. After decades of building trusted consumer brands, there was a natural opportunity to support founders applying those same standards to pet care. TAW Ventures is my way of helping raise the bar for pet health, wellness, and longevity, so more pets like Thaddeus can live happier, healthier lives for as long as possible.

‍

‍

‍

You recently partnered with Leap Venture Studio. How did that relationship come together, and what excites you most about working with them?

Leap Venture Studio has an extraordinary track record—nine cohorts, dozens of companies, and a clear commitment to making the world better for pets by making care more accessible and sustainable. When we started talking, it was clear we were aligned on both mission and mindset. They sit at the center of the early-stage pet ecosystem and have built a platform that pairs funding with real company-building support.

For TAW Ventures, joining Leap felt like the right way to amplify our impact. We bring a perspective rooted in brand strategy, category creation, and scaling mission-driven products, along with a deep focus on pet wellness and longevity. Leap brings the accelerator infrastructure, global reach, and a community of mentors and experts from Mars Petcare and Michelson Found Animals. What excites me most is helping founders translate breakthrough ideas into trusted, scalable brands.

Through Cohort 10, we can support companies through both capital and the kind of hands-on guidance that prepares them for commercialization and long-term success.

‍

What lessons from building beauty brands actually translate to pet, and just as importantly, what doesn't?

In prestige beauty, quality and safety are table stakes. You invest in formulation, testing, and education so consumers understand what they're using and why it works. The strongest brands are built around three things: real efficacy, clear communication, and a deep respect for the consumer's intelligence. The same should be true in the pet industry.

Another lesson is that brands are built over time, not in a single campaign. Long-term brand equity comes from consistency, transparency, and listening closely to the consumers you serve. Pet brands have the same opportunity—to become trusted partners in daily rituals, whether that's feeding, supplements, or care around aging and recovery.

What differs is the context. In pet, you are working even more directly at the intersection of medical decision-making, veterinary expertise, and the human–animal bond. The storytelling and brand-building muscles from beauty are incredibly relevant, but they must be integrated with veterinary science and regulatory standards. It's not about applying a beauty gloss to pet—it's about bringing a proven standard of trust and rigor into a category that deserves it.

‍

Beauty is a category built on trust and long-term brand equity. How do you evaluate that same level of trust when looking at pet companies today?

In beauty, trust is about quality, transparency, and science-backed claims. In pet, I look for similar signals, but through the lens of health and well-being. We ask questions like: How was this product developed? Are veterinarians, nutrition experts, or researchers meaningfully involved? Is the science robust and communicated in a way that pet parents can understand? What does the brand do after the sale—do they educate, listen, and evolve, or do they disappear?

Ingredient integrity and transparency are also critical. Pet parents deserve to know what they're giving their animals and why. The companies that build real brand equity will be the ones that welcome scrutiny, share data responsibly, and acknowledge both the benefits and limits of what they offer. That's the kind of trust that compounds over time.

‍

You've said you're not a “typical” investment firm — so where do you fundamentally see the market differently, especially with so much capital now flowing into pet?

We see capital as the starting point, not the end point. TAW Ventures was designed to be a trusted, category-defining partner in pet health, wellness, and longevity. That means we care as much about how a company builds its brand, communicates with pet parents, and upholds its standards as we do about its top-line growth.

Our model is built around three pillars: the Investment Team, TAW Studio, and our Advisory Board. TAW Studio is particularly important—it's our internal team that helps founders with brand, communications, and strategic growth. We work alongside portfolio companies on positioning, narrative, and consumer experience, because in categories built on trust, those pieces can be as important as the product itself.

We also take a long-term, purpose-driven view. There is a lot of capital flowing into pet, and that can create pressure for quick wins. We're more interested in founders who want to raise standards across the category—who are comfortable with patient capital and disciplined growth and see success not just as an exit, but as contributing to a stronger, more evidence-based industry. The pet industry is not a zero-sum game.

‍

What signals tell you a pet company—or a founder—is truly worth backing?

On the company side, focus is a big signal. The strongest concepts usually solve a clearly defined problem, rather than chasing every adjacent trend. We look closely at the evidence behind a product: Is it research- and vet-backed? Are early outcomes—clinical or consumer—compelling? Does the offering improve everyday wellness, prevention, recovery, aging, or quality of life in a way that's meaningful?

On the founder side, integrity and curiosity stand out. I pay attention to how a founder talks about safety, about the responsibility they feel toward pets and pet parents, and how they respond to hard questions. Founders who are open to feedback, eager to collaborate with experts, and willing to adapt tend to build stronger, more resilient companies.

Another important signal is how they think about the human–animal bond. The companies that resonate most with us understand that they're not just in the pet category—they're in the business of supporting relationships that are central to people's lives.

‍

What's one of the more unexpected or memorable pitches you've received—whether because of the idea, the founder, or the story behind it?

One of the pitches that has stayed with me focused on senior pets and end-of-life care. It wasn't flashy, but it was deeply thoughtful. What made it memorable was the balance of empathy and discipline. The founder understood the emotional weight of those moments but also had a very pragmatic plan for how to support pet parents in a scalable way.

It was a reminder that innovation in pet isn't only about early life or performance—it also means showing up thoughtfully at the end of life, when the relationship matters more than ever.

Those are the kinds of ideas that reinforce why TAW Ventures exists: to support solutions that raise standards, improve quality of life, and acknowledge the full lifespan of the human–animal bond.

‍

If we zoom out 10 years, what does pet health become, and where do you think people today are underestimating the ceiling?

Ten years from now, pet health will be much more holistic and proactive than it is today. Prevention, early detection, and longevity-focused care will be built into everyday life—through functional nutrition, diagnostics, supplements, and services designed to keep pets healthier for longer, not just treat issues after they appear.

At TAW Ventures, we think about this in two pillars: proactive health and support, and curative health and support. On the proactive side, there is enormous opportunity in products that improve health span—mirroring the broader shift in human health toward prevention and lifestyle. On the curative side, as pets live longer, they naturally encounter more age-related challenges such as mobility issues, chronic pain, or recovery needs after illness or surgery, which makes thoughtful, evidence-based solutions increasingly important.

Where I think people underestimate the ceiling is in the impact this will have on human well-being. As we get better at supporting pet longevity and quality of life, we also reinforce the routines, emotional connections, and sense of responsibility that are so important for human health. Investing in pet health is also an investment in the humans on the other end of the leash—the way they live, the routines they keep, and the support they feel as they age alongside their animals.